Telomerase activation in cervical cancer

American Journal of Pathology

Volumn 151, Issue 1, 1997, Pages 25-31

  Anderson, Suzanne ^a,b   Shera, Katherine ^a   Ihle, Jennifer ^a   Billman, Lisa ^a   Goff, Barbara ^a   Greer, Benjamin ^b   Tamimi, Hisham ^a   McDougall, James ^c   Klingelhutz, Aloysius ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CARCINOGENESIS; CONDYLOMA; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; WART VIRUS;

ADENOCARCINOMA; CARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TELOMERASE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0030747661     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Howley PM: Role of the human papillomaviruses in human cancer. Cancer Res 1991, 51:5019s-5022s
2. Munger K. Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989, 63:4417-4421
3. Kaur P, McDougall JK, Cone RC: Immortalization of primary human epithelial cells by cloned cervical carcinoma DNA containing human papillomavirus type 16 E6/E7 open reading frames. J Gen Virol 1989, 70:1261-1266
4. Hudson JB, Bedell MA, McCance DJ, Laimons LA: Immortalization and altered differentiation of human keratincytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol 1990, 64:519-526
5. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT: HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 1989, 8:3905-3910
6. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H: Structure and tran-scription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314:111-114
7. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990, 248:76-79
8. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136
9. Dyson N, Howley PM, Munger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243:934-937
10. Scheffner M, Munger K, Byrne JC, Howley PM: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991, 88:5523-5527
11. Klingelhutz AJ, Foster SA, McDougall JK: Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996, 380:79-82
12. Chen JJ, Reid CE, Band V, Androphy EJ: Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 1995, 269:529-531
13. Desaintes C, Hallez S, Van Alphen P, Burny A: Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J Virol 1992, 66:325-333
14. Thomas M, Massimi P, Jenkins J, Banks L: HPV-18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation. Oncogene 1995, 10:261-268
15. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992, 89:10114-10118
16. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutât Res 1991, 256:271-282
17. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988, 85:6622-6626
18. Zakian VA: Structure and function of telomeres. Annu Rev Genet 1989, 23:579-604
19. Blackburn EH: Structure and function of telomeres. Nature 1991, 350:569-573
20. Sandell LL, Zakian VA: Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 1993, 75:729739
21. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992. 1929, 11:1921
22. Wright WE, Shay JW: Telomere positional effects and the regulation of cellular senescence. Trends Genet 1992, 8:193-197
23. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990. 345:458-460
24. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346:866-868
25. Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ: In vivo loss of telomeric repeats with age in humans. Mutât Res 1991, 256:45-48
26. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB: Telomere end-replication problem and cell aging. J Mol Biol 1992, 225:951-960
27. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, Piatyszek MA, Wright WE, Shay JW: Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol 1994, 59:307-315
28. Linskens MH, Harley CB, West MD, Campisi J, Hayflick L: Replicative senescence and cell death. Science 1995, 267:17
29. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Ceil 1985, 43:405-413
30. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989, 59:521-529
31. Conn M, Blackburn EH: Telomerase in yeast. Science 1995, 269:396-400
32. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996, 18:173-179
33. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266: 2011-2015
34. Van der Haegen BA, Shay JW: Immortalization of human mammary epithelial cells by SV40 large T-antigen involves a two step mechanism. In Vitro Cell Dev Biol 1993, 29A:180-182
35. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S: Stabilization oî short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994, 68:3410-3414
36. Klingelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK: Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 1994, 14:961-969
37. Greider CW, Blackburn EH: The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987, 51:887-898
38. Greider W, Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989, 337:331-337
39. Harrington L, Hull C, Grillenden J, Greider C: Gel shift and UV cross-linking analysis of Tetrahymena telomerase. J Biol Chem 1995, 270:8893-8901
40. Collins K, Kobayashi R, Greider CW: Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 1995,81:677-686
41. Feng JL, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu JH, Le SY, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B: The RNA component of human telomerase. Science 1995, 269:1236-1241
42. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996, 56:645-650
43. Broccoli D, Young JW, de Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 92:9082-9086
44. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR: Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Ceils 1989, 7:209-214
45. Resnick RM, Cornelissen MTE, Wright DK, Eichinger GH, Fox HS, Schegget J, Manos MM: Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990, 82:1477-1484
46. Lungu O, Wright TC, Silverstein S: Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 1992, 6:145-152
47. Crum CP, McLachlin CM: Cervical intraepithelial neoplasia. J Cell Biochem 1995, 23:71-79
48. McDougall J: Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 1994, 186:101-119
49. Shay JW, Wright WE: Telomerase activity in human cancer. Curr Opin Oncol 1996, 8:66-71
50. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995, 55:2533-2536
51. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995, 1:249-255
52. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 1996, 88:116-122
53. Wright WE, Shay JW, Piatyszek MA: Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995, 23:3794-3795